Hansen Gwenn — SEC insider filings
SEC reporting owner CIK 1817160. 50 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 50 filings on record, filed 2020-12-01 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 45 legs across 40 filings — 80,920 shares, $1,627,229 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 151.
- Largest priced transaction: sale of 4,356 shares @ $25.00 ($108,900) in Nurix Therapeutics, Inc., filed 2026-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | 50 | — | 45 legs · 80,920 sh · $1,627,229 | 151 |
Insider filings — Hansen Gwenn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Option exercise (M): 3,573 @ $0 · Sale (S): 3,957 @ $26.28 · Option exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $26.80 · +4 more | EDGAR |
| 2026-10-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $25 · Option exercise (M): 1,452 (derivative) @ $0 | EDGAR |
| 2026-09-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,452 @ $1.86 · Sale (S): 1,452 @ $25.47 · Option exercise (M): 1,452 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 1,500 @ $23.87 · Sale (S): 2,611 @ $24.64 | EDGAR |
| 2026-08-05 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 4,356 @ $1.86 · Sale (S): 4,356 @ $25 · Option exercise (M): 4,356 (derivative) @ $0 | EDGAR |
| 2026-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 3,847 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-25 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 5,394 @ $20 | EDGAR |
| 2026-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,214 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-10 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 31,333 @ $0.84 · Option exercise (M): 31,333 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 4,797 @ $16.58 · Sale (S): 98 @ $17.37 · +4 more | EDGAR |
| 2025-10-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 4,087 @ $12.80 · Option exercise (M): 3,207 (derivative) @ $0 · +3 more | EDGAR |
| 2025-10-23 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 4,308 @ $12.01 · Option exercise (M): 3,207 (derivative) @ $0 · +3 more | EDGAR |
| 2025-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,206 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,377 @ $11.50 · Option exercise (M): 3,206 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-02-13 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 34,300 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,357 @ $19.81 · Sale (S): 333 @ $20.33 · Option exercise (M): 3,207 (derivative) @ $0 · +2 more | EDGAR |
| 2024-10-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,437 @ $24.30 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 3,408 @ $20.67 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,206 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 2,007 @ $12.04 · Option exercise (M): 3,206 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 2,334 @ $7.99 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-11-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,633 @ $5.20 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-08-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,884 @ $9.65 · Option exercise (M): 3,207 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,206 @ $0 · Sale (S): 1,136 @ $9.88 · Option exercise (M): 3,206 (derivative) @ $0 | EDGAR |
| 2023-02-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 88,900 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2023-02-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Sale (S): 1,412 @ $11.78 · Option exercise (M): 3,207 (derivative) @ $0 | EDGAR |
| 2022-11-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Sale (S): 1,165 @ $12.88 · Option exercise (M): 3,207 (derivative) @ $0 | EDGAR |
| 2022-08-10 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 60,298 (derivative) @ $0 | EDGAR |
| 2022-08-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,207 @ $0 · Sale (S): 1,186 @ $15.67 · Option exercise (M): 3,207 (derivative) @ $0 | EDGAR |
| 2022-05-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,206 @ $0 · Sale (S): 1,098 @ $11.75 · Option exercise (M): 3,206 (derivative) @ $0 | EDGAR |
| 2022-01-21 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 115,438 (derivative) @ $0 · Grant/award (A): 51,308 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Option exercise (M): 1,428 @ $9.57 · Sale (S): 1,828 @ $28.96 · Option exercise (M): 400 (derivative) @ $0 · Option exercise (M): 1,428 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $29.13 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-11-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $33.24 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-10-28 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $35 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-10-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $29.92 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-09-08 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,600 @ $7.26 · Sale (S): 1,600 @ $35 · Option exercise (M): 1,600 (derivative) @ $0 | EDGAR |
| 2021-09-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $32.34 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-08-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $31.21 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $26.76 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-06-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $27.74 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 800 @ $7.26 · Sale (S): 800 @ $34.99 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
| 2021-04-06 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $35 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $7.26 · Sale (S): 400 @ $31.55 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2021-03-16 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 800 @ $7.26 · Sale (S): 800 @ $45 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 800 @ $7.26 · Sale (S): 800 @ $35.95 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
| 2021-02-22 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 800 @ $7.26 · Sale (S): 600 @ $35.81 · Sale (S): 200 @ $37.67 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
| 2021-02-12 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2020-12-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 12,000 @ $0.84 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs